Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - PolyMedica Corporation (NasdaqNM:PLMD)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Recent Events
Aug 22Price hit new 52-week low ($9.50)
Aug  6Conference call: PolyMedica Corporation Responds to Allegations of Medicare Fraud
July 24Conference call: PolyMedica Corporation Earnings (Q1)
Location
11 State Street
Woburn, MA 01801
Phone: (781) 933-2020
Fax: (781) 933-7992
Employees (last reported count): 1,043
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Free Annual Report
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 600 SmallCap
Ownership
·Insider and 5%+ Owners: 19%
·Over the last 6 months:
 · one insider buy; 15.0K shares (0.6% of insider shares)
 · one insider sell; 8,000  shares
  (0.3% of insider shares)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
PolyMedica Corporation is a provider of direct-to-consumer specialty medical products and services, conducting business in the Chronic Care, Professional Products and Consumer Healthcare markets. The Company sells diabetes supplies and related products through its Chronic Care segment. The Company provides direct-to-consumer prescription respiratory supplies and services to Medicare-eligible seniors suffering from chronic obstructive pulmonary disease (COPD) and also markets, manufactures and distributes a line of prescription urological and suppository products through its Professional Products segment. The Company's AZO products for urinary health are distributed primarily to food and drug retailers and mass merchandisers nationwide through its Consumer Healthcare segment.
More from Market Guide: Expanded Business Description

Financial Summary
PolyMedica Corporation is a nationwide provider of direct-to-consumer specialty medical products and services, primarily focused on the diabetes supply and consumer healthcare markets. For the three months ended 6/30/01, net revenues rose 25% to $63 million. Net income before accounting change increased 44% to $8.6 million. Revenues reflect increased sales from the Chronic Care and Professional Products segment. Earnings benefited from improved margins.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2001 Compensation
PayExer

Steven Lee, 54
Chairman and CEO
$1.6M$1.6M
Arthur Siciliano, Ph.D., 58
Pres and Pres of PolyMedica Pharmaceuticals (U.S.A.), Inc.
1.1M590K
Stephen Farrell, 36
CFO
--  --  
Eric Walters, 49
Exec. VP and Clerk
603K288K
John Reed
Sr. VP of Marketing and CMO
--  --  
Dollar amounts are as of 31-Mar-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:PLMDAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Aug-2001
$9.50 
Recent Price$12.65 
52-Week High
on 30-Oct-2000
$61.50 
Beta1.11 
Daily Volume (3-month avg)1.23M
Daily Volume (10-day avg)1.06M
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-64.4%
52-Week Change
relative to S&P500
-52.2%
Share-Related Items
Market Capitalization$159.2M
Shares Outstanding12.6M
Float10.2M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$12.70 
Earnings (ttm)$2.39 
Earnings (mrq)$0.65 
Sales (ttm)$17.22 
Cash (mrq)$2.96 
Valuation Ratios
Price/Book (mrq)1.00 
Price/Earnings (ttm)5.29 
Price/Sales (ttm)0.73 
Income Statements
Sales (ttm)$232.7M
EBITDA (ttm)$78.0M
Income available to common (ttm)$32.3M
Profitability
Profit Margin (ttm)13.9%
Operating Margin (ttm)21.6%
Fiscal Year
Fiscal Year EndsMar 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)16.45%
Return on Equity (ttm)20.91%
Financial Strength
Current Ratio (mrq)5.71 
Debt/Equity (mrq)0.02 
Total Cash (mrq)$38.3M
Short Interest
As of 8-Aug-2001
Shares Short8.57M
Percent of Float84.0%
Shares Short
(Prior Month)
8.20M
Short Ratio4.05 
Daily Volume2.12M
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.